ロード中...
MERS-CoV spike protein: Targets for vaccines and therapeutics
The disease outbreak caused by Middle East respiratory syndrome coronavirus (MERS-CoV) is still ongoing in the Middle East. Over 1700 people have been infected since it was first reported in September 2012. Despite great efforts, licensed vaccines or therapeutics against MERS-CoV remain unavailable....
保存先:
| 出版年: | Antiviral Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113765/ https://ncbi.nlm.nih.gov/pubmed/27468951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.07.015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|